OMEGA 3

Plant-based sourced 
Omega 3 (DHA) 

SUPPORTS HEALTHY BRAIN FUNCTION 
AND BRAIN DEVELOPMENT 

The Omega 3 fat DHA is the predominant structural fatty acid in the central nervous system and retina and its availability is crucial for improved brain development and brain ageing. 

Several studies have linked Omega 3 intake to decreased age-related mental decline and even to a reduced risk of Alzheimer's disease. Results to-date also suggest that DHA is more effective the earlier it is ‘started’, meaning at a young age, and that it most effectively used in conjunction with antioxidants. 

DHA intake during preschool years may also have a beneficial role in the prevention of attention deficit hyperactivity disorder (ADHD) and enhancing learning capability and academic performance. In fact, Several research studies have shown that children with ADHD have lower blood levels of omega-3 fatty acids than children with ADHD. 
Furthermore, it has been shown that omega-3 supplements can reduce symptoms of ADHD, such as inattention, hyperactivity, impulsiveness, restlessness and aggression. 

Omega-3 supplements are beneficial to help prevent and treat depression and anxiety. Research has shown that people who regularly take Omega 3 supplements are less likely to suffer from depression and anxiety, and that people with depression or anxiety had a reduction in symptoms, after they started to take Omega-3 supplements. 

Some studies have indeed shown that people with psychiatric disorders tend to have lower levels of Omega-3 and that Omega-3 supplementation has shown to reduce the frequency of mood swings and relapses in people with both schizophrenia and bipolar disorder. 

Low levels of DHA are also linked to lower levels of the hormone melatonin, responsible for sleep. Taking Omega-3 fatty acid DHA has shown to improve the length and quality of your sleep. 

the main benefits of omega 3

Change this text

Change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
CLINICAL RESEARCH CONDUCTED WITH OMEGA 3
(A SELECTION)
  • Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. - LINK https://pubmed.ncbi.nlm.nih.gov/25954194/ 
  • Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain and retina - LINK https://pubmed.ncbi.nlm.nih.gov/2136947/ 
  • Essential fatty acids, DHA and human brain - LINK https://pubmed.ncbi.nlm.nih.gov/15812120/ 
  • The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina - LINK https://pubmed.ncbi.nlm.nih.gov/15555528/ 
  • Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association - LINK https://pubmed.ncbi.nlm.nih.gov/19262590/ 
  • Inadequate supply of vitamins and DHA in the elderly: implications for brain aging and Alzheimer-type dementia - LINK https://pubmed.ncbi.nlm.nih.gov/25592004/ 
  •  Short-term supplementation of acute long-chain omega-3 polyunsaturated fatty acids may alter depression status and decrease symptomology among young adults with depression: A preliminary randomized and placebo controlled trial - LINK https://pubmed.ncbi.nlm.nih.gov/26188642/ 
  • Omega-3 fatty acids and the treatment of depression: a review of scientific evidence - LINK https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976923/ 
  • Omega-3 Fatty Acids and Depression: Scientific Evidence and Biological Mechanisms - LINK https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976923/ 
  • Therapeutic use of omega-3 fatty acids in bipolar disorder - LINK https://pubmed.ncbi.nlm.nih.gov/21721919/ 
  • Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial - LINK https://pubmed.ncbi.nlm.nih.gov/21784145/ 
  • Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial - LINK https://pubmed.ncbi.nlm.nih.gov/22640930/ 
  • Omega-3 fatty acids in inflammation and autoimmune diseases - LINK https://pubmed.ncbi.nlm.nih.gov/12480795/ 
  • Historical overview of n-3 fatty acids and coronary heart disease - LINK https://pubmed.ncbi.nlm.nih.gov/18541598/ 
  • A meta-analysis shows that docosahexaenoic acid from algal oil reduces serum triglycerides and increases HDL-cholesterol and LDL-cholesterol in persons without coronary heart disease - LINK https://pubmed.ncbi.nlm.nih.gov/22113870/ 
  • A fish a day, keeps the cardiologist away! – A review of the effect of omega-3 fatty acids in the cardiovascular system - LINK https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712371/ 
  • Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity - LINK https://pubmed.ncbi.nlm.nih.gov/19593941/ 
  • The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus - LINK https://pubmed.ncbi.nlm.nih.gov/15290734/ 
  • Supplementation of fish oil and olive oil in patients with rheumatoid arthritis - LINK https://pubmed.ncbi.nlm.nih.gov/15723739/ 
  • Study on the use of omega-3 fatty acids as a therapeutic supplement in treatment of psoriasis - LINK https://pubmed.ncbi.nlm.nih.gov/21760742/ 
  • Calcium metabolism, osteoporosis and essential fatty acids: a review - LINK https://pubmed.ncbi.nlm.nih.gov/9624425/ 
  • Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis - LINK https://pubmed.ncbi.nlm.nih.gov/21961774/ 
  • Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study - LINK https://pubmed.ncbi.nlm.nih.gov/19436468/ 
  • Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial - LINK https://pubmed.ncbi.nlm.nih.gov/22541055/ 
  • Dietary factors and fluctuating levels of melatonin - LINK https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402070/ 
  • Fatty acids and sleep in UK children: subjective and pilot objective sleep results from the DOLAB study--a randomized controlled trial - LINK https://pubmed.ncbi.nlm.nih.gov/24605819/